## ページ 1

 
Kiwa Cermet Italia 
Kiwa Cermet Italia S.p.A. – Single-member company subject to management and coordination of Kiwa Italia Holding Srl 
Headquarters: Via Cadriano 23, 40057 - Granarolo dell’Emilia (BO) 
Tel. +39.051.4593.111 - Fax +39.051.763.382 - info@kiwacermet.it - www.kiwa.it 
VAT Registration No. 00627711203 – Tax ID 03502820370 – Share capital: € 1.000.000,00 i.v. 
1
 
 
MEDICAL DEVICES DIVISION 
Granarolo dell’Emilia (BO), 2024/09/10  
CL1/V4a 
 
Esteemed 
 
JSKBiomed Inc.  
#509, 272-16, Munji-ro, Yuseong-gu, Daejeon, Republic of Korea 
 
Notified Body Confirmation Letter Reference:  CERBO0551924 
To whom it may concern, 
 
Confirmation of the status of a formal application, written agreement, and appropriate 
surveillance in the framework of Regulation EU 2023/607 amending Regulations (EU) 2017/745 and 
(EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro 
diagnostic medical devices 
 
This letter confirms that, Kiwa Cermet Italia S.p.a., a Notified Body (NB) designated against 
Regulation (EU) 2017/745 (MDR) and identified by the number 0476 on NANDO, has received a 
formal application in accordance with Section 4.3, first subparagraph of Annex VII of MDR and has 
signed a written agreement in accordance with Section 4.3, second subparagraph of Annex VII of 
MDR with the following manufacturer:  
 
JSKBiomed Inc.  
#509, 272-16, Munji-ro, Yuseong-gu, Daejeon, Republic of Korea 
SRN Number (if available): KR-MF-000040867 
 
The devices covered by the formal application and the written agreement mentioned above are 
identified in the Tables below. Table 1 identifies the devices for which an MDR application has been 
received, written agreement concluded and for which the NB is also responsible for appropriate 
surveillance of the corresponding devices under the applicable Directive. Table 2 identifies the 
devices for which an MDR application has been received and a written agreement concluded, but the 
NB has not yet taken the responsibility for appropriate surveillance of the corresponding devices 
under the applicable Directive. 
 
In the case of devices covered by certificates issued under Directive 90/385/EEC (AIMDD) or Directive 
93/42/EEC (MDD) that expired after 26 May 2021 and before 20 March 2023, without having been 
withdrawn, this letter also confirms that the manufacturer signed the written agreement under MDR 
by the date of MDD/AIMDD certificate expiry; or provided evidence that a competent authority of a 
Member State had granted a derogation or exemption from the applicable conformity assessment 


## ページ 2

 
Kiwa Cermet Italia 
Kiwa Cermet Italia S.p.A. – Single-member company subject to management and coordination of Kiwa Italia Holding Srl 
Headquarters: Via Cadriano 23, 40057 - Granarolo dell’Emilia (BO) 
Tel. +39.051.4593.111 - Fax +39.051.763.382 - info@kiwacermet.it - www.kiwa.it 
VAT Registration No. 00627711203 – Tax ID 03502820370 – Share capital: € 1.000.000,00 i.v. 
1
procedure in accordance with Article 59(1) of MDR or Article 97(1) of the MDR respectively, by the 20 
Mar 2023 for the relevant devices. 
 
The transition timelines that apply to the devices covered by this letter, subject to the 
manufacturer’s continued compliance to the other conditions specified in Article 120.3c of MDR (as 
amended by (EU) 2023/607), are shown below: 
• 
26 May 2026 for Class III custom-made implantable devices  
• 
31 December 2027 for Class III devices and Class IIb implantable devices excluding Well-
established technologies (WET - sutures, staples, dental fillings, dental braces, tooth crowns, 
screws, wedges, plates, wires, pins, clips and connectors) 
• 
31 December 2028 for other Class IIb devices, Class IIa, Class I devices placed on the market 
in sterile condition or have a measuring function 
• 
31 December 2028 for devices not requiring the involvement of a notified body under MDD 
but requiring it under MDR (e.g., class I devices that qualify as re-usable surgical instruments) 
 
 
On behalf of the Notified Body, 
Dr.ssa Frabetti Alessia 
Medical Device Division Manager 
 
 
 
 
Firmato digitalmente
da: ALESSIA
FRABETTI
Data: 10/09/2024
13:53:15


## ページ 3

 
Kiwa Cermet Italia 
Kiwa Cermet Italia S.p.A. – Single-member company subject to management and coordination of Kiwa Italia Holding Srl 
Headquarters: Via Cadriano 23, 40057 - Granarolo dell’Emilia (BO) 
Tel. +39.051.4593.111 - Fax +39.051.763.382 - info@kiwacermet.it - www.kiwa.it 
VAT Registration No. 00627711203 – Tax ID 03502820370 – Share capital: € 1.000.000,00 i.v. 
1
 
Table 1: Devices covered by this letter and for which the NB is also responsible for appropriate 
surveillance of the corresponding devices under the applicable Directive: 
Device name or Basic 
UDI-DI (under MDR 
application) 
MDR Device classification 
(as proposed by the 
manufacturer and verified 
at the pre-application 
stage) 
If the MDR device is a 
substitute device, 
identification of the 
corresponding MDD/AIMDD 
device  
MDD/AIMDD Certificate 
Reference(s) of the devices 
under MDR application, 
and the NB Identification 
- 
- 
- 
- 
 
Table 2: Devices covered by this letter and for which the NB is NOT responsible for appropriate 
surveillance of the corresponding devices under the applicable Directive: 
Device name or Basic 
UDI-DI (under MDR 
application) 
MDR Device classification 
(as proposed by the 
manufacturer and verified 
at the pre-application 
stage) 
If the MDR device is a 
substitute device, 
identification of the 
corresponding 
MDD/AIMDD device  
MDD/AIMDD Certificate 
Reference(s) of the devices 
under MDR application, and 
the NB Identification 
Sterile, single use needle-
free injector 
Class IIa 
 
 Identification of the 
corresponding device under 
MDD 
 
 Same  
 Substitute  
 
Certificate No. : 
n.0068/QCO-DM/213-2020 
 
NB No. : 0068 
 
 
 
 
 
 
 
 
 
Confirmation Letter Revision History 
Date 
NB internal reference 
traceable to each version 
of the letter 
Action 
2024/09/10 
Rev.00 
Initial issue 
 
 
 
 
 
 
 
For further information on the content of the letter or verification of the validity of the letter please 
contact medical@kiwa.com  or phone at +39.051.4593.111  

